Shanghai Labway Clinical Laboratory Co., Ltd.
SHZ: 301060.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Weixiong Zeng
- Employees
- 1,365
- Headquarters
- Shanghai, China
- IPO year
- 2021
- Market cap
- CN¥4.3B
- Website
- https://www.labway.cn
Loading 301060…
Loading profile data…Frequently asked questions about 301060
What does Shanghai Labway Clinical Laboratory Co., Ltd. (301060.SZ) do?
Shanghai Labway Clinical Laboratory Co., Ltd. offers sales services for in vitro diagnostic products; and medical laboratory services. Shanghai Labway Clinical Laboratory Co., Ltd. was founded in 1993 and is based in Shanghai, China.
Where does 301060.SZ trade?
Shanghai Labway Clinical Laboratory Co., Ltd. (301060.SZ) trades on the Shenzhen Stock Exchange.
What sector is 301060.SZ in?
Shanghai Labway Clinical Laboratory Co., Ltd. (301060.SZ) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Shanghai Labway Clinical Laboratory Co., Ltd.?
Weixiong Zeng is the chief executive officer of Shanghai Labway Clinical Laboratory Co., Ltd. (301060.SZ).
Where is Shanghai Labway Clinical Laboratory Co., Ltd. headquartered?
Shanghai Labway Clinical Laboratory Co., Ltd. is headquartered in China.
Does 301060.SZ pay a dividend?
Yes — Shanghai Labway Clinical Laboratory Co., Ltd. (301060.SZ) paid a trailing twelve-month dividend of CNY 0.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 301060.SZ go public?
Shanghai Labway Clinical Laboratory Co., Ltd. (301060.SZ) completed its initial public offering in 2021.